Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
AstraZeneca
Age
18–150
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Male/ female with solid, malignant tumour which is unresponsive to standard therapies (Phase I). Female patients with advanced breast cancer with low HER2 expression (Phase II)
Suitable for paclitaxel chemotherapy
Life expectancy more than 12 weeks
You may not be if
Inadequate kidney, liver, heart, gastric, lung or eye function
Hypersensitive to paclitaxel
No symptomatic uncontrolled brain metastases
Previous taxane chemotherapy within 12 months (Phase II)
Clareo Health | Phase I/II AZD8931/Paclitaxel in Treatment of Advanced Solid Tumours (Phase I) and Advanced Breast Cancer (Phase II)
